Transcriptional Profiling and Genetic Mapping of Barley Responses to Bacterial Flagellin.

Diverse plant species detect bacterial flagellin using leucine-rich repeat receptor-like kinases (LRR RLKs) to activate defense responses and promote resistance against bacterial invasion. In barley, the impact of flagellin on inducible defense responses has not been fully described. Here, we report that the flagellin-derived flg22 peptide induces callose, ROS bursts and differential expression of 2603 genes in barley.

Blackfoot Words: a database of Blackfoot lexical forms.

This paper describes the structure and creation of Blackfoot Words, a new relational database of lexical forms (inflected words, stems, and morphemes) in Blackfoot (Algonquian; ISO 639-3: bla). To date, we have digitized 63,493 individual lexical forms from 30 sources, representing all four major dialects, and spanning the years 1743-2017. Version 1.

Pharmacological Predictors of Morbidity and Mortality in COVID-19.

The interaction of coronavirus disease (COVID-19) with the majority of common prescriptions is broadly unknown. The purpose of this study is to identify medications associated with altered disease outcomes in COVID-19. A retrospective cohort composed of all adult inpatient admissions to our center with COVID-19 was analyzed.

Inpatient Omission of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Is Associated With Morbidity and Mortality in Coronavirus Disease 2019.

Purpose: Due to the affinity of severe acute respiratory syndrome coronavirus 2 for the human angiotensin-converting enzyme 2 (ACE2) receptor, use of ACE inhibitors and angiotensin receptor blockers (ARBs) has been a major concern for clinicians during the 2020 pandemic. Meta-analyses have affirmed that these agents do not worsen clinical outcomes in patients with severe acute respiratory syndrome coronavirus 2 infection. To date, only a limited number of studies have directly evaluated the safety of inpatient prescription of ACE inhibitors/ARBs during acute coronavirus disease 2019 (COVID-19) illness.

A Case of Euglycemic Diabetic Ketoacidosis in a Patient With Type 2 Diabetes Mellitus and COVID-19.

Diabetic ketoacidosis (DKA) can cause significant morbidity and mortality in patients with type 1 or type 2 diabetes mellitus. DKA causes an approximate annual hospitalization rate of 6.3% and in-hospital case-fatality rate of 0.